Doma Holdings Inc is a technology-driven company that specializes in transforming the real estate title and closing process
By leveraging innovative software solutions and data analytics, Doma aims to streamline the traditional title insurance and escrow process, making real estate transactions faster, more efficient, and more accessible. The company's offerings include automated title searches, risk assessment, and digital closing services, catering to a wide range of clients including lenders, real estate professionals, and homebuyers. Doma's mission is to enhance the experience of property transactions by reducing costs and improving transparency in the title insurance industry.
The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the "Greed" zone on Monday. U.S. stocks closed mostly lower on Monday, with the Dow Jones index closing lower by more than 200 points during the session.
U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.3% on Monday. The Dow traded down 0.67% to 39,538.91 while the NASDAQ fell 0.06% to 16,369.44. The S&P 500 also fell, dropping, 0.30% to 5,238.49.
Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results.
U.S. stocks traded lower midway through trading, with the Dow Jones falling over 300 points on Monday. The Dow traded down 0.79% to 39,492.80 while the NASDAQ fell 0.22% to 16,344.11. The S&P 500 also fell, dropping, 0.45% to 5,230.46.
U.S. stocks traded mixed this morning, with the Dow Jones falling over 200 points on Thursday. The Dow traded down 0.57% to 39,580.90 while the NASDAQ rose 0.30% to 16,427.97. The S&P 500 also fell, dropping, 0.07% to 5,250.56.
Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings shares jumped 34.1% to $6.09 in pre-market trading
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular Dystrophy.
